Breakthrough News: Yako Wins Top Spot in Global Cytokine Citation Rankings with EGF, Ranking 46th Among Top 3 Domestic Brands!
Recently, the prestigious international database CiteAb officially released its 2024 Global Top 100 Highly Cited Cytokines list. Abbkine's Human EGF protein (Product Code: PRP100159) stood out with its exceptional scientific impact, securing the 46th position globally. This achievement not only highlights the product's robust capabilities but also underscores the global scientific community's high regard for Abbkine's quality.
International platform certification, data speaks for itself
As a globally authoritative platform for citing research reagents, CiteAb's annual rankings are objectively generated based on global literature citation data, serving as a key indicator of product quality and practical value. Abbkine's Human EGF protein competes with world-leading brands and stands out among numerous global options, demonstrating its exceptional quality. It has become the preferred tool for researchers in cell culture, signal transduction, and cancer research.
Star Application Case: Supporting the Frontier Research of Glioma
Notably, this product has recently been cited in a research paper published in a high-level academic journal ("GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas"). The study thoroughly explores how GINS2 modulates glioma sensitivity to temozolomide chemotherapy through the EGR1/ECT2 pathway, using Human EGF protein from Abbkine Subfamily Bio (the paper also utilized Human bFGF protein from Abbkine). This not only demonstrates the product's reliability in complex disease model and mechanism research but also highlights its capability to provide critical support for cutting-edge scientific discoveries.
Document link：GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas
Looking ahead, continuous innovation
"Being selected into CiteAb TOP100 is not the end, but a new starting point," said Ye Jian, founder of Yakeyin Biotech. "We will continue to increase R&D investment, expand our high-quality cytokine product line, and deepen collaborations with top-tier research institutions worldwide to advance life science research." The inclusion of Human EGF protein in this ranking represents another recognition of our product's excellence by the international scientific community. We anticipate that this well-established product, repeatedly validated through literature, will provide robust support for researchers in key areas such as cell function studies, drug development, and disease mechanism exploration.
